Description

3-Quinolinecarboxamide, n-[2-(1,1-Dimethylethyl)-5-Hydroxy-4-(2-Hydroxy-1,1-Dimethylethyl)Phenyl]-1,4-Dihydro-4-Oxo- is a sophisticated heterocyclic organic compound featuring a quinoline core with multiple functional groups, making it a valuable advanced intermediate for pharmaceutical research and development. Its complex structure is engineered to serve as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly targeting therapeutic areas requiring high molecular specificity. This compound is essential for R&D chemists and process development scientists in the pharmaceutical and biotechnology industries working on next-generation drug candidates.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic research.
• Active Pharmaceutical Ingredient (API) Development: Used as a core scaffold or advanced intermediate in the development and scale-up of new APIs.
• Medicinal Chemistry Research: Provides a versatile template for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Biochemical Research: May be utilized as a reference standard or probe compound in biochemical assays and target validation studies.
• Contract Manufacturing (CMO): Supplied to contract manufacturing organizations for custom synthesis and process development under cGMP guidelines.
• Academic Research: Employed in university and institutional labs for cutting-edge organic synthesis methodology and heterocyclic chemistry studies.

Basic Information

Product Name	3-Quinolinecarboxamide, n-[2-(1,1-Dimethylethyl)-5-Hydroxy-4-(2-Hydroxy-1,1-Dimethylethyl)Phenyl]-1,4-Dihydro-4-Oxo-
CAS No.	1246213-23-9
Molecular Formula	C24H28N2O4
Molecular Weight	408.49 g/mol
Synonyms	N-[2-tert-Butyl-5-hydroxy-4-(2-hydroxy-2-methylpropyl)phenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide; 3-Quinolinecarboxamide, N-[2-(1,1-dimethylethyl)-5-hydroxy-4-(2-hydroxy-1,1-dimethylethyl)phenyl]-1,4-dihydro-4-oxo-; 4-Oxo-1,4-dihydroquinoline-3-carboxamide derivative; tert-Butyl hydroxy phenyl dihydrooxoquinoline carboxamide; Advanced Quinoline Intermediate
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards for advanced pharmaceutical intermediates. We employ validated analytical methods including HPLC, NMR, and MS to guarantee identity, purity, and consistency. Certificates of Analysis (COA) are available upon request, detailing batch-specific results. Our quality system is designed to support development under research and cGMP guidelines as required.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and/or hygroscopic; handle and store under an inert atmosphere if specified for your grade.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.